Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Dupilumab can cause rare hair loss, but switching treatments can restore hair and control eczema.

Baricitinib is effective and safe for treating severe alopecia areata.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Baricitinib shows promise for treating various skin conditions beyond alopecia areata.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Accurate diagnosis and personalized treatment are crucial in dermatopathology.

Tofacitinib can help regrow hair in about 50% of people with moderate-severe alopecia areata.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.